Search Results - "Maierson, E."

Prospective Assessment of Chronic Lung Allograft Dysfunction (CLAD); the Clinical Trials in Organ Transplantation (CTOT) Study Experience by Frankel, C.W., Kopetskie, H., Sever, M., Cosgrove, M., Kirchner, J., Robien, M., Williams, N., Reynolds, J.M., Arroyo, K., Shah, P., Mathew, J., Budev, M.M., Maierson, E., Singer, L.G., Islam, A., Belperio, J.A., Weigt, S.S., Punzalan, E., Neely, M., Todd, J.L., Snyder, L.D., Palmer, S.M.

“…Diagnosis of CLAD after lung transplantation (LT) requires sustained decline in lung function and exclusion of other etiologies for the decline. The…”
Get full text

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial) by Lincoff, A.Michael, Bittl, John A, Kleiman, Neal S, Sarembock, Ian J, Jackman, J.Daniel, Mehta, Sameer, Tannenbaum, Mark A, Niederman, Alan L, Bachinsky, William B, Tift-Mann, J, Parker, H.Graham, Kereiakes, Dean J, Harrington, Robert A, Feit, Frederick, Maierson, Elizabeth S, Chew, Derek P, Topol, Eric J

“…To assess the efficacy of the direct thrombin inhibitor bivalirudin relative to heparin during contemporary coronary intervention, 1,056 patients who underwent…”
Get full text

Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: Results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET) by Lincoff, A.Michael, Kleiman, Neal S., Kottke-Marchant, Kandace, Maierson, Elizabeth S., Maresh, Kelly, Wolski, Katherine E., Topol, Eric J.

“…Background The direct thrombin inhibitor bivalirudin has previously been associated with better efficacy and lower hemorrhage risk than heparin during balloon…”
Get full text